News

Winnacunnet High School senior Joe Labrecque has transformed his battle with a rare chronic illness into a mission to help ...
"The newer medications that are coming out, and a lot of them are approved, are much more focused on the problem," explains ...
Myasthenia gravis (MG) is a rare, chronic autoimmune disorder that disrupts the communication between nerves and muscles. It ...
The Food and Drug Administration (FDA) has approved Imaavy™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis (gMG) in adult and pediatric patients aged 12 years and older who are ...
The approval marks the second international approval for rozanolixizumab (Rystiggo; UCB Pharma) for generalized myasthenia ...
The US Food and Drug Administration (FDA) has approved nipocalimab (Imaavy) injection for the treatment of adults and children aged 12 and older with generalized myasthenia gravis (gMG) who ...
Johnson & Johnson won U.S. approval on April 30, 2025, of its new drug Imaavy for generalized myasthenia gravis. 37,530 people played the daily Crossword recently. Can you solve it faster than ...
People who take IMAAVY™ should not receive ... Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study. The Lancet Regional Health - Western ...
Prescribing information warns against administering the drug to people with active infections. "We consistently hear from individuals living with myasthenia gravis who are hopeful for new ...
“FDA’s approval of IMAAVYTM (nipocalimab-aahu) is an important step in expanding treatment options for people living with myasthenia gravis,” said Donald S. Wood, PhD, President and ...
While Johnson & Johnson isn't the first to secure FDA approval for an FcRn-blocking antibody in myasthenia ... gravis (gMG). The green light, which J&J says covers the “broadest population of ...
Imaavy is the first FcRn blocker approved for anti-AChR and anti-MuSK antibody positive patients with generalized myasthenia gravis. The Food and Drug Administration (FDA) has approved Imaavy ...